N1BI34.SA

Neurocrine Biosciences Inc. · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$15.85B

PE Ratio

119.83

EV to Ebitda

—

Earnings Yield

1.00%

Revenue (TTM)

$613.8M

Net Income (TTM)

$132.3M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

42.00%

Profit Margin

22.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core5 fields›

Market Cap$15.85B

Revenue TTM$613.8M

Shares Outstanding2.01B

Insider Ownership0.00%

Institutional Ownership0.00%

Growth Estimates6 fields›

Revenue Growth (Quarterly YoY)42.00%

Rev Growth Est 1Y Forward0.2

EPS Growth (Quarterly YoY)2311.00%

EPS Growth Est Quarterly0

CFO Growth (Quarterly YoY)125.00%

FCF Growth (Quarterly YoY)153.00%

Operations21 fields›

Revenue TTM$613.8M

Gross Margin TTM64.00%

Gross Margin (Quarterly)98.00%

Operating Margin TTM23.00%

Operating Margin (Quarterly)23.00%

Operating Expenses TTM$10.5M

Profit Margin TTM22.00%

Profit Margin (Quarterly)24.00%

Net Income TTM$132.3M

EPS TTM1.61

EPS (Quarterly)0.1

EBIT Margin TTM17.74%

EBITDA Margin TTM27.00%

EBITDA TTM$163.9M

CFO % of Revenue TTM48.00%

CFO % of Revenue (Quarterly)18.00%

CFO TTM$294.7M

Capex % of Revenue TTM3.00%

Capital Expenditures$20.3M

FCF % of Revenue (Quarterly)24.00%

FCF TTM$164.5M

Efficiency1 fields›

ROA12.00%

Valuation11 fields›

P/E (TTM)119.83

P/E Forward21.19

PEG0.42

P/CFO53.79

P/FCF96.38

EV/Revenues (TTM)4.64

Price To Book23.51

Price to Tangible Book23.51

Earnings Yield1.00%

FCF Yield1.00%

Payout Ratio0.00%

Liquidity6 fields›

Cash Per Share14.79

Current Ratio3.39

Total Assets$970.6M

Total Liabilities$1.06B

Shareholders Equity$674.1M

Interest Expense$10.5M

Yields3 fields›

Payout Ratio0.00%

Earnings Yield1.00%

Buyback Yield2.00%